Figure F-20 is titled “Change in CAPS for exposure compared with control, by type of comparator: Sensitivity analysis including present centered therapy and high risk of bias studies.” This figure displays a forest plot reporting the weighted mean difference in CAPS scores stratified by exposure therapy compared to waitlist, exposure therapy compared to usual care, and exposure therapy compared to present centered therapy. The plot depicts a greater reduction in CAPS scores for patients treated with exposure therapy than waitlist (6 trials, weighted mean difference −27.21, 95% CI −32.29 to −22.13, I2 = 0.0%), usual care (1 trial, weighted mean difference −41.30, 95% CI −63.47 to −19.13), or present centered therapy (2 trials, weighted mean difference −6.94, 95% CI −12.96 to −0.91, I2 = 0.0%). The overall analysis favored exposure therapy (weighted mean difference −23.99, 95% CI −32.72 to −15.26, I2 = 74.9%).

Figure F-20Change in CAPS for exposure therapy compared with control, by type of comparator: Sensitivity analysis including present centered therapy and high risk of bias studies

Note: Difede et al., 2007, Ready et al., 2010, and Johnson et al., 2006 were rated as having a high risk of bias.

Timing of outcome assessment: 8 weeks (Basoglu, 2007), 24 weeks (Difede, 2007), 6 to 9 sessions (Johnson, 2006), 6 weeks (Resick, 2002), 4.5 weeks (Rothbaum, 2005), “post-treatment” or 8 to 15 weeks (Asukai, 2010), 10 sessions (Ready, 2010), 10 weeks (Schnurr, 2007).

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.